STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Codexis to Participate in Cantor Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
conferences

Codexis (NASDAQ:CDXS), a provider of enzymatic solutions for therapeutic manufacturing, announced its participation in the upcoming Cantor Global Healthcare Conference. The event will take place from September 3-5, 2025, in New York.

The company's management will engage in a fireside chat on September 4, 2025, at 3:55 pm ET. Investors can access a live webcast through Codexis's investor relations website, with a replay available for 90 days after the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

REDWOOD CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend the Cantor Global Healthcare Conference, being held September 3-5, 2025, in New York, New York.

Management will participate in a fireside chat on Thursday, September 4, 2025, at 3:55 pm ET. A live webcast of the event will be available in the Investor Relations section of the Company’s website, https://ir.codexis.com. A replay will be archived for 90 days following the event.

About Codexis

Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, leveraging its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis® manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.

For More Information

Investor Contact
Georgia Erbez
650-421-8100

ir@codexis.com


FAQ

When is Codexis (CDXS) presenting at the Cantor Global Healthcare Conference 2025?

Codexis management will participate in a fireside chat on Thursday, September 4, 2025, at 3:55 pm ET.

How can investors watch Codexis's presentation at the Cantor Healthcare Conference?

Investors can watch the live webcast through Codexis's investor relations website at https://ir.codexis.com. A replay will be available for 90 days after the event.

Where is the 2025 Cantor Global Healthcare Conference being held?

The Cantor Global Healthcare Conference is being held in New York, New York from September 3-5, 2025.

What type of company is Codexis (CDXS)?

Codexis is a leading provider of enzymatic solutions specializing in the efficient and scalable manufacturing of complex therapeutics.
Codexis Inc

NASDAQ:CDXS

CDXS Rankings

CDXS Latest News

CDXS Latest SEC Filings

CDXS Stock Data

149.04M
87.72M
2.28%
80.74%
5.54%
Biotechnology
Industrial Organic Chemicals
Link
United States
REDWOOD CITY